Moderna, Inc. SEC filings MRNA
Moderna, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-I/A | Filing | Dec 16, 2025 | — |
| SC TO-I/A | Filing | Nov 18, 2025 | — |
| SC TO-I | Filing | Nov 13, 2025 | — |
| SC TO-C | Filing | Nov 12, 2025 | — |
| SC TO-C | Filing | Nov 6, 2025 | — |
| SC TO-C | Filing | Oct 21, 2025 | — |
| SC TO-C | Filing | Oct 10, 2025 | — |
| SC TO-C | Filing | Oct 3, 2025 | — |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| CORRESP | Letter to the SEC | Apr 28, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2023 | — |
| PX14A6G | Filing | Apr 13, 2023 | — |
| PX14A6G | Filing | Mar 25, 2022 | — |
| PX14A6G | Filing | Mar 21, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 16, 2021 | — |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MRNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1682852
- Former names
- Moderna Therapeutics, Inc. (until Aug 24, 2016)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.